Jun 7, 2021 08:05AM

Jun 7, 2021 08:00AM

May 10, 2021 07:35AM

May 10, 2021 07:30AM

May 3, 2021 07:31AM

May 3, 2021 07:30AM

Apr 22, 2021 07:30AM Intra-Cellular Therapies Announces Investor Webcast and Presentations on Lumateperone Programs at the Upcoming American Psychiatric Association (APA) Annual Meeting

Apr 20, 2021 07:00AM

Apr 19, 2021 09:05AM

Apr 12, 2021 07:30AM

Feb 25, 2021 07:30AM

Feb 24, 2021 07:30AM

Feb 22, 2021 08:09AM

Feb 22, 2021 08:00AM Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA® (lumateperone) for the Treatment of Bipolar Depression

Jan 21, 2021 08:09AM

Jan 21, 2021 08:00AM

Dec 29, 2020 08:01AM

Dec 29, 2020 08:00AM

Dec 9, 2020 08:00AM

Nov 9, 2020 07:30AM

Sep 9, 2020 07:01AM Intra-Cellular Therapies (ITCI) Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar Depression Met the Primary Endpoint

Sep 9, 2020 07:00AM

Aug 10, 2020 07:30AM

Jun 29, 2020 08:01AM

Jun 29, 2020 08:00AM

May 7, 2020 07:30AM

Apr 2, 2020 08:00AM

Mar 23, 2020 07:30AM Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia

Mar 2, 2020 07:31AM

Mar 2, 2020 07:30AM

Feb 20, 2020 05:00PM

Dec 24, 2019 04:36AM

Dec 23, 2019 10:31AM

Dec 23, 2019 10:17AM

Dec 23, 2019 10:16AM Intra-Cellular Therapies (ITCI) IV at 120 after announces FDA approval of CAPLYTA

Dec 23, 2019 08:44AM

Dec 23, 2019 07:36AM

Dec 23, 2019 07:00AM

Dec 23, 2019 06:59AM

Dec 12, 2019 07:31AM

Dec 12, 2019 07:30AM

Dec 4, 2019 08:00AM Intra-Cellular Therapies to Present Data on Lumateperone and ITI-333 at the 58th Annual Meeting of the American College of Neuropsychopharmacology

Nov 5, 2019 07:30AM

Oct 29, 2019 08:00AM

Sep 30, 2019 08:00AM

Sep 25, 2019 07:30AM

Sep 10, 2019 09:11AM

Sep 10, 2019 07:44AM

Sep 10, 2019 07:30AM Intra-Cellular Therapies Provides Lumateperone Regulatory Update

Aug 7, 2019 08:00AM

151,992 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All